2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$7.02+$0.010 (+0.14%)
Price as of Oct 22, 2026 7:30 PM EDT- $568.7MMarket Cap
- -47.77%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$7.02+$0.010 (+0.14%)
PHAT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.01 | ||
Change | -$0.28 (-3.83%) | ||
Open | $7.04 | ||
High | $7.22 | ||
Low | $6.96 | ||
Previous Close | $7.03 | ||
Volume | 811,714 | ||
30-Day Average Volume | 1,279,207 | ||
1-Week Change | -5.00% | ||
1-Month Change | -5.64% | ||
1-Year Change | -47.77% | ||
3-Year Change | -24.08% | ||
5-Year Change | -76.17% | ||
Fundamentals | |||
Shares Outstanding | 80.9M | ||
Total Assets | $327.1M | ||
Market Cap | $568.7M | ||
Enterprise Value | $550.8M | ||
Period: QTR TTM FY | |||
Revenue | $74.3M | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $142.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -2 | ||
P/E | -33 | ||
PEG | -1 | ||
Price/Free Cash Flow | -288 | ||
Price/Operating Cash Flow | -295 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue